• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Merck KGaA doubles up on AI partners, tapping BenevolentAI and Exscientia for drug...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 20, 2023 at 08:42: AM
via Merck KGaA is spreading its bets on an artificial-intelligence-enabled future for drug discovery, inking similar three-target deals with BenevolentAI and Exscientia. The deals are collectively worth more than $30 million upfront and $1 billion in potential milestones.

article source
 




Top Bottom
Back
Quote